Literature DB >> 12658347

Histological classification of ovarian cancer.

Tsunehisa Kaku1, Shinji Ogawa, Yoshiaki Kawano, Yoshihiro Ohishi, Hiroaki Kobayashi, Toshio Hirakawa, Hitoo Nakano.   

Abstract

The histology of ovarian tumors exhibits a wide variety of histological features. The histological classification of ovarian tumors by the World Health Organization (WHO) is based on histogenetic principles, and this classification categorizes ovarian tumors with regard to their derivation from coelomic surface epithelial cells, germ cells, and mesenchyme (the stroma and the sex cord). Epithelial ovarian tumors, which are the majority of malignant ovarian tumors, are further grouped into histological types as follows: serous, mucinous, endometrioid, clear cell, transitional cell tumors (Brenner tumors), carcinosarcoma, mixed epithelial tumor, undifferentiated carcinoma, and others. Clear cell and endometrioid carcinomas are highly associated with endometriosis. In stage distribution, serous carcinoma is found predominantly is stage III or IV. In contrast, clear cell and endometrioid carcinomas tend to remain confined to the ovary. Clear cell and endometrioid carcinomas may be unique histological types compared with serous carcinomas with respect to stage distribution and association with endometriosis.

Entities:  

Mesh:

Year:  2003        PMID: 12658347     DOI: 10.1007/s007950300002

Source DB:  PubMed          Journal:  Med Electron Microsc        ISSN: 0918-4287


  64 in total

Review 1.  Protein biomarkers of ovarian cancer: the forest and the trees.

Authors:  Brian M Nolen; Anna E Lokshin
Journal:  Future Oncol       Date:  2012-01       Impact factor: 3.404

2.  Clear Cell Adenocarcinofibroma Ovary - A Rare Histopathological Variant with Unusual Presentation.

Authors:  Manjit Kaur; Navtej Singh; Amrit Pal Singh Rana
Journal:  J Clin Diagn Res       Date:  2016-05-01

Review 3.  Unexpected gynecologic findings during abdominal surgery.

Authors:  Casey A Boyd; Taylor S Riall
Journal:  Curr Probl Surg       Date:  2012-04       Impact factor: 1.909

Review 4.  Differentiating rectal carcinoma by an immunohistological analysis of carcinomas of pelvic organs based on the NCBI Literature Survey and the Human Protein Atlas database.

Authors:  Koh Miura; Kazuyuki Ishida; Wataru Fujibuchi; Akihiro Ito; Hitoshi Niikura; Hitoshi Ogawa; Iwao Sasaki
Journal:  Surg Today       Date:  2012-03-23       Impact factor: 2.549

5.  Membranous expressions of Lewis y and CAM-DR-related markers are independent factors of chemotherapy resistance and poor prognosis in epithelial ovarian cancer.

Authors:  Lian-Cheng Zhu; Jian Gao; Zhen-Hua Hu; Carlton L Schwab; Hui-Yu Zhuang; Ming-Zi Tan; Li-Mei Yan; Juan-Juan Liu; Dan-Ye Zhang; Bei Lin
Journal:  Am J Cancer Res       Date:  2015-01-15       Impact factor: 6.166

6.  The zinc finger gene ZIC2 has features of an oncogene and its overexpression correlates strongly with the clinical course of epithelial ovarian cancer.

Authors:  Sergio Marchini; Elizabeth Poynor; Richard R Barakat; Luca Clivio; Michela Cinquini; Robert Fruscio; Luca Porcu; Cecilia Bussani; Maurizio D'Incalci; Eugenio Erba; Michela Romano; Giorgio Cattoretti; Dionyssios Katsaros; Andrew Koff; Lucio Luzzatto
Journal:  Clin Cancer Res       Date:  2012-06-25       Impact factor: 12.531

7.  Nodal status--its impact on prognosis in advanced ovarian cancer.

Authors:  C Bachmann; S Bachmann; T Fehm; A Staebler; S Becker; R Rothmund; C Gardanis; E M Grischke; D Wallwiener; E F Solomayer
Journal:  J Cancer Res Clin Oncol       Date:  2011-11-22       Impact factor: 4.553

8.  Proteome profiling of human epithelial ovarian cancer cell line TOV-112D.

Authors:  Jean-Philippe Gagné; Pierre Gagné; Joanna M Hunter; Marie-Eve Bonicalzi; Jean-François Lemay; Isabelle Kelly; Cécile Le Page; Diane Provencher; Anne-Marie Mes-Masson; Amaud Droit; David Bourgais; Guy G Poirier
Journal:  Mol Cell Biochem       Date:  2005-07       Impact factor: 3.396

9.  Matrix metalloproteinase-8 promoter gene polymorphisms in Mexican women with ovarian cancer.

Authors:  Fabian Arechavaleta-Velasco; Rocio Cuevas-Antonio; Pablo Dominguez-Lopez; Isaias Estrada-Moscoso; Fazlollah Shahram Imani-Razavi; Moises Zeferino-Toquero; Laura Diaz-Cueto
Journal:  Med Oncol       Date:  2014-07-18       Impact factor: 3.064

10.  KLK6 and KLK13 predict tumor recurrence in epithelial ovarian carcinoma.

Authors:  N M A White; M Mathews; G M Yousef; A Prizada; C Popadiuk; J J E Doré
Journal:  Br J Cancer       Date:  2009-10-06       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.